Health ❯ Medical Treatments

Gene Therapy

Clinical Trials CRISPR Technology Duchenne Muscular Dystrophy Experimental Treatments Genetic Disorders Sickle Cell Disease Casgevy Hereditary Angioedema Auditory Neuropathy Personalized Medicine AADC Deficiency Hearing Restoration Huntington's Disease Regulatory Affairs Retinal Diseases Stem Cell Therapy CAR-T Cell Therapy Duchenne's Muscular Dystrophy Parkinson's Disease CAR T-cell Therapy Surgical Procedures Hemophilia Treatment Adeno-Associated Virus CRISPR

Vertex Projects Casgevy Sales Above $100 Million in 2025 as CRISPR Therapeutics Waits for Payoff

Casgevy’s months-long, center-based treatment model is slowing early sales.

FDA Adds Boxed Warning to Elevidys, Narrows Use to Ambulatory Patients 4 and Older

NEJM Study Finds 95% Long-Term Success for ADA-SCID Gene Therapy

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

FDA Lifts Hold on Elevidys Shipments to Ambulatory Duchenne Patients

AAV-OTOF Gene Therapy Restores Hearing in Teens and Adults

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

Personalized CRISPR Therapy Sends Baby KJ Home from CHOP